These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 107613)

  • 1. Immobilization of the plasminogen activator streptokinase and its fibrinolytic effects in vivo.
    Mercer LC; Everse KE; Holmes AW; Everse J
    Thromb Res; 1978 Dec; 13(6):931-40. PubMed ID: 107613
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of beta-sitosterol on the fibrinolytic potential in rabbits.
    Hoffmann A; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):189-96. PubMed ID: 2459019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and fibrinolysis in rats poisoned with mercuric chloride.
    Michalska M; Mirowski M; Wierzbicki R
    Pol J Pharmacol Pharm; 1988; 40(4):365-71. PubMed ID: 3146750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current developments in fibrinolytic therapy].
    Rijken DC
    Ned Tijdschr Geneeskd; 1985 Sep; 129(37):1768-72. PubMed ID: 3934567
    [No Abstract]   [Full Text] [Related]  

  • 6. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
    Bachmann F
    Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative ex vivo study of plasminogen activators and proteases for fibrinolytic activity and side effects in rabbits.
    Janik BA; Papaioannou SE
    Thromb Haemost; 1977 Feb; 37(1):154-61. PubMed ID: 576512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the effects of tranexamic acid and its isobenzedrine ester on plasminogen activation and streptokinase induced fibrinolysis.
    Baldacci M; Catalani R; Bartoli C; Del Corso A; Tozzi MG; Mura U
    Boll Soc Ital Biol Sper; 1989 Jun; 65(6):521-8. PubMed ID: 2611013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
    Verheijen JH; Rijken DC; Chang GT; Preston FE; Kluft C
    Thromb Haemost; 1984 Jul; 51(3):396-7. PubMed ID: 6437007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of caffein ingestion on plasma fibrinolytic potential.
    Wojta J; Kirchheimer JC; Peska MG; Binder BR
    Thromb Haemost; 1988 Apr; 59(2):337-8. PubMed ID: 3133816
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolytic therapy--plasminogen activator inhibitors].
    Hönigl K; Pilger E; Stark G; Bertuch H
    Vasa Suppl; 1988; 26():103-6. PubMed ID: 3144048
    [No Abstract]   [Full Text] [Related]  

  • 12. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activation: biochemistry, physiology, and therapeutics.
    Wun TC
    Crit Rev Biotechnol; 1988; 8(2):131-48. PubMed ID: 2976309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
    Lucore CL; Fujii S; Sobel BE
    Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human plasma plasminogen activator].
    Batista Diaz A
    Probl Gematol Pereliv Krovi; 1982; 27(1):40-4. PubMed ID: 6801643
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro effects of aspirin in fibrinolysis.
    Iatridis PG; Iatridis SG; Markidou SG; Ragatz BH
    Haemostasis; 1974; 3(1):55-64. PubMed ID: 4279872
    [No Abstract]   [Full Text] [Related]  

  • 18. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
    Nilsson IM; Ljungnér H; Tengborn L
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids.
    Crutchley DJ; Conanan LB; Maynard JR
    Ann N Y Acad Sci; 1981; 370():609-16. PubMed ID: 6455956
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin effect on the release of plasminogen activator inhibitors by human platelets.
    Woods AI; Lazzari MA
    Thromb Res; 1988 Oct; 52(2):119-25. PubMed ID: 3143164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.